How pharmacy benefit managers influence drug pricing скачать в хорошем качестве

How pharmacy benefit managers influence drug pricing

The point of prescription drugs is to help people improve their quality of life. When a doctor writes a prescription and sends it along to the pharmacy, oftentimes they’re more focused on the drug’s effectiveness than its cost. But when a patient picks up that drug, the price they will be asked to pay at the counter takes center stage — and it depends on a complex combination of factors. Is it a brand-name or a generic drug? Does the patient have health insurance? If so, does that insurance cover the drug? Also, how do health insurers decide which drugs to cover, and what amount they’ll cover? We answer all of these questions in Part 2 of this series. The video outlines what pharmacy benefit managers, or PBMs, are; how formularies and rebates work; and how PBMs use them to mediate with drugmakers, health insurers, and pharmacies in ways that influence the cost of drugs. More from STAT: Become a subscriber: https://www.statnews.com/stat-plus/ Watch Full Episodes:    / @statnews   Newsletters: https://www.statnews.com/signup/ STAT events: https://www.statnews.com/stat-events/ Facebook:   / statnews   Twitter:   / statnews   Instagram:   / statnews   Flipboard: rb.gy/3xnsxr STAT Reports: https://rb.gy/rexfwj STAT eBooks: https://rb.gy/eme3h5 ABOUT STAT: Founded in 2015, STAT is a global digital media brand that focuses on delivering fast, deep, and tough-minded journalism about the life sciences industries to over six million monthly site visitors and an additional 20 million readers on the Apple News app. STAT takes you inside academic labs, biotech boardrooms, and political backrooms, casting a critical eye on scientific discoveries, scrutinizing corporate strategies, and chronicling the roiling battles for talent, money, and market share. With an award-winning newsroom, STAT provides indispensable insights and exclusive stories on the technologies, personalities, power brokers, and political forces driving massive changes in the life sciences industry — and a revolution in human health.